ICCC News Alert Immucell Corp (ICCC) 4.76 11/13/2014 16:32:5

New Post Public Reply Private Reply Replies (0) Message Board

Nov 13, 2014 at 5:32 PM

Immucell Corp (ICCC) 4.76 $ICCC

ImmuCell's (ICCC) CEO Michael Brigham on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Nov 12, 8:09PM CST

ICCC: 4.76 (-0.01)

ImmuCell reports Q3 breakeven
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 4:17PM CST

ICCC: 4.76 (-0.01)

ImmuCell Announces Financial Results for Third Quarter of 2014
Marketwired - Wed Nov 12, 3:08PM CST
ImmuCell Corporation (NASDAQ: ICCC), a growing animal health company that is developing, manufacturing and selling products that improve animal health and productivity in the dairy and beef industries, today announced financial results for its third quarter ended September 30, 2014.
ICCC: 4.76 (-0.01)

ImmuCell reports November 12
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 1:50PM CST

ICCC: 4.76 (-0.01)

ImmuCell to Announce Third Quarter Fiscal Year 2014 Financial Results
Marketwired - Mon Nov 03, 7:01AM CST
ImmuCell Corporation (NASDAQ: ICCC) a growing animal health company that is developing, manufacturing and selling products that improve animal health and productivity in the dairy and beef industries, will report financial results for its third quarter fiscal year 2014 after the market closes on Wednesday, November 12, 2014. The Company has scheduled a conference call that same day Wednesday, November 12, 2014, at 4:30 pm EST to review the results.
ICCC: 4.76 (-0.01)

ImmuCell Participating at Multiple Dairy and Beef Industry Events Throughout September 2014
Marketwire - Wed Sep 17, 7:01AM CDT
ImmuCell Corporation (NASDAQ: ICCC) a growing animal health company that is developing, manufacturing and selling products that improve animal health and productivity in the dairy and beef industries, announced today that it will be participating in a number of large industry tradeshows throughout the month of September.
ICCC: 4.76 (-0.01)

ImmuCell Announces Financial Results for the Second Quarter of 2014
Marketwire - Tue Aug 12, 7:01AM CDT
ImmuCell Corporation (NASDAQ: ICCC), a growing animal health company that is developing, manufacturing and selling products that improve animal health and productivity in the dairy and beef industries, today announced financial results for its second quarter ended June 30, 2014.
ICCC: 4.76 (-0.01)

ImmuCell Initiates Pivotal Effectiveness Study to Prevent Calf Scours Caused by Rotavirus
Marketwire - Tue Jul 15, 7:02AM CDT
ImmuCell Corporation (NASDAQ: ICCC) a growing animal health company that is developing, manufacturing and selling products that improve animal health and productivity in the dairy and beef industries, announced today that it has commenced a pivotal effectiveness study designed to test antibodies derived from colostrum utilizing its proprietary technology against a bovine rotavirus challenge. The enrollment of calves for the pivotal effectiveness study is expected to be complete by the end of 2014, making product approval possible in 2015.
ICCC: 4.76 (-0.01)

ImmuCell Commences Manufacture of Nisin Necessary for Approval of Mast Out(R)
Marketwire - Wed Jul 09, 7:01AM CDT
ImmuCell Corporation (NASDAQ: ICCC) a growing animal health company that is developing, manufacturing and selling products that improve animal health and productivity in the dairy and beef industries, announced today that it has completed modifications to its manufacturing facility to produce pharmaceutical-grade Nisin, the active ingredient in its Mast Out(R) product, to address subclinical mastitis in lactating dairy cows.
ICCC: 4.76 (-0.01)

ImmuCell elects Paul R Wainman to board
M2 - Fri Mar 21, 5:53AM CDT
US-based animal health company ImmuCell (NASDAQ:ICCC) revealed on Thursday the addition of Paul R Wainman to its board of directors
ICCC: 4.76 (-0.01)

Paul R. Wainman Joins Board of Directors of ImmuCell Corporation
Marketwire - Thu Mar 20, 7:01AM CDT
ImmuCell Corporation (NASDAQ: ICCC) today announced that Mr. Paul R. Wainman has been appointed to its Board of Directors effective March 31, 2014.
ICCC: 4.76 (-0.01)

ImmuCell Announces Increase in Product Sales and Other Annual Financial Results
Marketwire - Thu Feb 13, 7:00AM CST
ImmuCell Corporation (NASDAQ: ICCC) today announced the results of its operations for the three-month and twelve-month periods ended December 31, 2013.
ICCC: 4.76 (-0.01)

OTC Daily Alert Stock Watch - ImmuCell Corporation (NASDAQ: ICCC)
WorldStockWire - Wed Sep 11, 9:15PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
ICCC: 4.76 (-0.01)

ImmuCell Corporation achieves 16% rise in product sales, with continued profitability
M2 - Tue Aug 13, 10:21AM CDT
Animal health company ImmuCell Corporation (NASDAQ:ICCC) on Monday reported a net income of USD6,000, or less than USD0.01 per share, for the three-month period ended 30 June 2013.
ICCC: 4.76 (-0.01)

ImmuCell Announces Increase in Product Sales and Continued Profitability
Marketwire - Mon Aug 12, 7:00AM CDT
ImmuCell Corporation (NASDAQ: ICCC) today announced the results of its operations for the three-month and six-month periods ended June 30, 2013.
ICCC: 4.76 (-0.01)

Nasdaq stocks posting largest volume increases
AP - Thu Jul 18, 5:05PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
JAKK: 6.61 (-0.24), ICCC: 4.76 (-0.01), ISIG: 2.92 (+0.04), KFFB: 8.16 (-0.09), CZFC: 12.05 (+0.03), GLDC: 4.30 (-0.10)

ImmuCell Suspends Mast Out(R) Partnering Effort; Pursuit of FDA Product Approval to Continue
Marketwire - Thu Jul 18, 7:01AM CDT
ImmuCell Corporation (NASDAQ: ICCC) today announced that it has suspended its active pursuit of a partner for Mast Out(R), its Nisin-based intramammary mastitis treatment product under development for dairy cows.
ICCC: 4.76 (-0.01)

First Defense(R) Is Now OMRI Listed and May Be Used With Certified Organic Dairy and Beef Cattle
Marketwire - Thu Jul 11, 7:00AM CDT
ImmuCell Corporation (NASDAQ: ICCC) today announced that First Defense(R), a USDA-approved scours preventative for newborn dairy and beef calves, has been reviewed by the Organic Materials Review Institute (OMRI) and has been listed with products eligible for use in certified organic production, subject to approval by USDA accredited certifiers.
ICCC: 4.76 (-0.01)

ImmuCell Announces Product Sales Increases and Other Financial Results
Marketwire - Thu Feb 14, 7:01AM CST
ImmuCell Corporation (NASDAQ: ICCC) today announced the results of its operations for the three-month and twelve-month periods ended December 31, 2012.
ICCC: 4.76 (-0.01)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Deadline Looms for EquipmentShare Investors' Legal Action

Pressure Builds for EquipmentShare Investors If you've thrown some cash into EquipmentShare.com Inc. (NASDAQ: EQPT), it's time to sit up and pay attention. There's smoke on the horizon, and Faruqi & Faruqi, LLP is waving the flag. They've got a securities class action spinning fast, and if you've suffered any losses, September 21, 2026, is a date you don't want to forget....

Cannabis Industry Pushes for Robust Financial Services

Industry Gears Up for Financial Action Clearly, cannabis businesses are shouting louder than a vendor at a ballgame, demanding more than just the basic chips-and-soda banking service. They’re on the hunt for serious credit facilities, payments, and the traditional financial tools that most sectors take for granted. I mean, check this out: Shield Compliance just dropped...

Albertsons Welcomes Once Upon a Coconut Nationwide

Coconut Water Takes Over Grocery Aisles You know, for all the cautious optimism I wield, this here is a move that shows real muscle in the world of coconut water—I mean, slamming into Albertsons' grocery empire is no small potatoes! Once Upon a Coconut has landed its premium hydration cans across all the banners under this giant retailer. From that good ol' familiar...

Helio Fred Garcia Honored by Diversity Action Alliance

Award Ceremony Set in the Big Apple In an industry where recognition often feels as transient as a ticker's daily high, the Diversity Action Alliance (DAA) is doing its bit to emphasize the lasting impact individuals can make. On September 16 in New York City, Helio Fred Garcia will be honored with the 2026 Pat Ford Larger Than Life Impact Award at the DAA's Annual...

WNET's 25th Anniversary 9/11 Tribute: Stories and Lessons

Reflecting on a Dark Day with WNET's Programming Nothing quite hits you like the anniversary of a colossal tragedy. The memories of September 11, 2001, remain etched in the urban landscape of New York City, and this year marks 25 years since that heart-wrenching day. The WNET Group steps up to the plate with a comprehensive slate of programming aimed at honoring the...

Woodpack Global Unveils Crate Design System: A New Era Begins

Innovating the Wooden Crate Landscape An old industry got a much-needed facelift today, folks. Woodpack Global has rolled out Crate Design System™ (CDS)—a snazzy new tool that's shaking up the wooden crate design landscape. It blows the dust off outdated design methods that have been collecting cobwebs since the '60s. That's right, we’re talking about a significant...

Sandbox VR Expands to Melbourne, Betting on Immersive Fun

Sandbox VR Ventures into Melbourne's Heart Every now and then, a venture takes its ambitions and rolls the dice on a prime location. Sandbox VR is swaggering into Melbourne's bustling Central Business District, fresh out of its success on the Gold Coast. Opening this Melbourne venue on September 14 marks a significant leap in the company's Aussie expansion—a bold nod to...

Navigating Land Access: The Hidden Roadblock in Mining

Mining's Often Overlooked Obstacle: Land Access In the world of mining, the shallow thrills of striking gold are often overshadowed by the frustrating slog of securing land access. You can have your permits lined up, your finances sorted, and drills humming along, but if you haven’t sweet-talked the folks farming above your visible vein of riches, you could be staring...

GBI Bio's New CEO Jesse McCool to Propel Growth

Jesse McCool stepping into GBI's CEO shoes is the kind of move that makes you sit up straight and take notice. Let me tell you, the biomanufacturing scene is buzzing with this appointment, and McCool's got his work cut out for him in leading GBI Biomanufacturing's shift towards commercial-scale operations while expanding their early-stage biotech portfolio. A Veteran in...

AbbVie's Bold Leap in Menstrual Migraine Treatment

AbbVie's Game-Changing Atogepant Study When it comes to pushing boundaries in the pharmaceutical world, there's no sitting on the fence. AbbVie's Phase 3 LUNA study results are painting a bright picture for women who suffer from the relentless grip of menstrual migraines. In a world where not a single treatment option has been approved specifically for this condition,...